SAN DIEGO – Edico Genome today announced the availability of its DRAGENTM Bio-IT Platform on Illumina’s BaseSpace® Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data. Powered by Amazon Web Services’ (AWS) new reconfigurable Field Programmable Gate Array (FPGA) enabled F1 instances, Edico Genome’s ultra-rapid DRAGEN Genome Pipeline features optimized […]

New deals in China, Israel, Russia, Benelux, Spain, Czech Republic and UK reflect strong demand for ultra-fast new thermal cycler Amsterdam: Dutch biotechnology company Molecular Biology Systems(MBS) continues to build its global sales network with the announcement today of new distributors for revolutionary NEXTGENPCR thermal cycler in China – PreMed Lab; Israel – Pronto Diagnostics; […]

Strategic Sponsorship Will Provide Innovative Technology and Nurture Promising Biotechnology Startup SANTA CLARA, Calif., and CAMBRIDGE, Mass. Agilent Technologies Inc. (NYSE: A) has announced a platinum sponsorship agreement with LabCentral, a biotech innovation hub based in Cambridge, Massachusetts. LabCentral is an independent, shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups. […]

Announcing the Single-Cell Printer for documented isolation of cells in clonal cell line development Sunnyvale, Calif. – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated microfluidics-based technology and real-time image analysis […]

MassARRAY Insights providers will aid in results interpretation San Diego, CA – Agena Bioscience, a global provider of molecular genetic solutions and Molecular Health, a leader in cloud-based decision support technology for precision medicine, have entered into a strategic partnership, whereby Molecular Health Guide®(MH Guide) analysis platform will aid interpretation of raw data generated by […]

Panel of antibodies developed at Mount Sinai will enable first multiplexed potency assay for tracking neuraminidase in flu vaccines CREDIT: INDEVR, INC. InDevR, a Boulder-based progressive analytical technology and life science instrumentation company today announced that it has entered into an exclusive, world-wide license agreement for monoclonal antibodies developed by scientists at the Icahn School […]

Cologne (DE) / Basel (CH) – Lonza has today introduced the CytoSMART™ 2 System, an updated version of Lonza’s popular CytoSMART™ System for live cell imaging. The CytoSMART™ 2 Device features an advanced optical system and more powerful camera unit, which enables researchers to capture higher-resolution images of their cell cultures. Images taken can be digitally […]

Dendritic cells are a key contributor to developing cancer vaccines   SANTA ANA, California: Irvine Scientific, a world leader in cell culture media development and manufacture, today announced the introduction of PRIME-XV® Dendritic Cell Maturation CDM, a chemically-defined, animal component-free medium for the differentiation of monocytes into immature dendritic cells, and subsequent maturation in dendritic cells. Current […]

Supports continued growth of HTG’s clinical diagnostic business TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that is has successfully completed an audit of its Quality Management System for continued certification to ISO 13485. This certification was issued by a registrar accredited under the […]

A new microscope that can capture 3D images of live organisms in real time: this is the QIs-scope, an innovation from a spinoff of Universidad Carlos III de Madrid (UC3M), 4D Nature. The microscope can be used in biomedical research or to improve clinical diagnosis procedures. This new-generation microscope can make three-dimensional images of small […]